Does Low Iron Cause Miscarriage?
The evidence linking iron deficiency directly to miscarriage is inconclusive and contradictory, but emerging high-quality research suggests that treating iron deficiency may significantly reduce miscarriage risk, while the protective role of mild physiologic anemia during pregnancy complicates this relationship.
Current State of Evidence
The U.S. Preventive Services Task Force (USPSTF) states that "many observational studies have explored the association between adverse maternal and infant health outcomes (such as postpartum hemorrhage, preterm birth, low birthweight, and perinatal death) and iron deficiency or iron deficiency anemia in pregnancy, but findings have been inconclusive" 1. The 2024 USPSTF reaffirmed this position, concluding that current evidence is insufficient to determine whether screening or supplementation for iron deficiency affects maternal and infant health outcomes 2.
The Contradictory Evidence
Evidence Supporting Iron Deficiency as a Risk Factor
The most compelling recent evidence comes from a 2025 Finnish cohort study of 292 women with infertility and iron deficiency. After treatment with intravenous iron (ferric carboxymaltose), miscarriage rates dropped dramatically from 28% to 13%, while live birth rates increased from 26% to 51% 3. In adjusted models, iron treatment was associated with significantly lower miscarriage rates (OR = 0.32; 95% CI = 0.20-0.52; p < 0.001) 3.
A 2025 global burden of disease analysis identified iron deficiency as a critical risk factor for maternal abortion and miscarriage, particularly in low sociodemographic index regions and among women aged 20-34 4.
Evidence Against Iron Deficiency as a Risk Factor
Paradoxically, a 2015 Russian case-control study (n=421) found that mild anemia appeared protective against pregnancy loss. Women who delivered live births had 90.3% odds of having mild anemia compared to those with pregnancy loss, suggesting a protective role 5. This aligns with the concept that physiologic hemodilution during pregnancy serves an adaptive function, preventing severe disseminated intravascular coagulation during labor 5.
Clinical Implications and Practical Approach
Key Distinction: Severity Matters
The contradiction may be resolved by recognizing that:
- Severe iron deficiency (ferritin ≤30 μg/L) appears harmful and associated with increased miscarriage risk 3
- Mild physiologic anemia (hemoglobin 100-110 g/L) may be protective due to hemodilution effects 5
- High hemoglobin levels (≥146 g/L) are associated with increased stillbirth risk 5
Screening Recommendations
Despite insufficient evidence for universal screening according to USPSTF guidelines 1, 2, practical clinical approach should include:
- Measure hemoglobin/hematocrit at first prenatal visit and again in second/third trimester
- Check serum ferritin if hemoglobin <110 g/L or in high-risk patients
- High-risk groups requiring attention: vegetarians, short interpregnancy intervals, gastrointestinal disease, non-Hispanic Black and Mexican American women, multiparous women 1
Treatment Approach
For confirmed iron deficiency (ferritin ≤30 μg/L):
- Oral iron: 60-120 mg elemental iron daily for treatment 1
- Standard prenatal vitamins contain 30 mg elemental iron for prevention 1
- Intravenous iron (ferric carboxymaltose) for severe deficiency or oral intolerance, based on emerging evidence of superior outcomes 3
Avoid over-supplementation: Do not aggressively treat mild physiologic anemia (hemoglobin 100-110 g/L) without documented iron deficiency, as this may eliminate protective hemodilution 5.
Important Caveats
- Most studies linking iron deficiency to adverse outcomes were conducted in populations with different nutritional status and parasite burden than the United States 1
- Serum ferritin is an acute phase reactant and may be falsely elevated during inflammation 1
- Physiologic hemodilution makes hemoglobin/hematocrit alone imprecise for diagnosing true iron deficiency 1
- The clinical significance of improving hematologic indices without proven impact on pregnancy outcomes remains unclear per USPSTF 1
Bottom Line for Practice
Screen women with risk factors for iron deficiency and treat documented severe deficiency (ferritin ≤30 μg/L), as emerging evidence suggests this reduces miscarriage risk 3. However, avoid aggressive treatment of mild physiologic anemia without confirmed iron deficiency, as this may be counterproductive 5. The standard 30 mg elemental iron in prenatal vitamins is reasonable for prevention in average-risk women 1.